Header Logo

Connection

JESSIAN MUNOZ to Humans

Back to Details
This is a "connection" page, showing publications JESSIAN MUNOZ has written about Humans.
JESSIAN MUNOZ
Connection Strength
0.692
Humans
  1. 4-French Aortic Balloon Occlusion in Cesarean Hysterectomy for Placenta Accreta Spectrum Disorder. Obstet Gynecol. 2025 Jun 01; 145(6):732-738.
    View in: PubMed
    Score: 0.027
  2. Conservative management of placenta accreta spectrum is associated with improved surgical outcomes compared to cesarean hysterectomy: a systematic review and meta-analysis. Am J Obstet Gynecol. 2025 May; 232(5):432-452.e3.
    View in: PubMed
    Score: 0.026
  3. Surgical Outcomes and Associated Morbidity of Active and Expectant Management of Second-Trimester Placenta Accreta Spectrum (PAS). Medicina (Kaunas). 2025 Jan 14; 61(1).
    View in: PubMed
    Score: 0.026
  4. Clinical Characteristics and Outcomes of Intrauterine Blood Transfusion (IUT) for Infectious Etiologies. Prenat Diagn. 2024 12; 44(13):1622-1627.
    View in: PubMed
    Score: 0.026
  5. Mental Health Assessments for Fetal Interventions. J Clin Psychiatry. 2024 Jun 24; 85(3).
    View in: PubMed
    Score: 0.025
  6. Risk factors for intensive care unit admission after cesarean hysterectomy for placenta accreta spectrum. Int J Gynaecol Obstet. 2024 Nov; 167(2):656-662.
    View in: PubMed
    Score: 0.025
  7. Association between Antenatal Vaginal Bleeding and Adverse Perinatal Outcomes in Placenta Accreta Spectrum. Medicina (Kaunas). 2024 Apr 22; 60(4).
    View in: PubMed
    Score: 0.025
  8. Perinatal outcomes of fetoscopic selective laser photocoagulation for spontaneous twin-anemia polycythemia sequence. Prenat Diagn. 2024 07; 44(8):965-970.
    View in: PubMed
    Score: 0.025
  9. Outcomes of fetal lower urinary tract obstruction based on?timing of oligohydramnios onset. Prenat Diagn. 2024 02; 44(2):131-137.
    View in: PubMed
    Score: 0.024
  10. Risk factors of massive blood transfusion (MTP) in cesarean hysterectomy for placenta accreta spectrum. Eur J Obstet Gynecol Reprod Biol. 2024 Feb; 293:32-35.
    View in: PubMed
    Score: 0.024
  11. An obstetric-specific surgical Apgar score predicts maternal morbidity from cesarean hysterectomy for placenta accreta spectrum. Int J Gynaecol Obstet. 2024 Mar; 164(3):912-917.
    View in: PubMed
    Score: 0.024
  12. Risk of Severe Maternal Morbidity in Patients with Placenta Accreta Spectrum Disorders Referred from Rural Communities to a Regional Placenta Accreta Spectrum Center. Am J Perinatol. 2023 12; 40(16):1738-1744.
    View in: PubMed
    Score: 0.024
  13. Factors Limiting Magnetic Resonance Imaging Diagnosis of Placenta Accreta Spectrum. Am J Perinatol. 2023 10; 40(13):1398-1405.
    View in: PubMed
    Score: 0.023
  14. Preterm birth and foetal-neonatal death rates associated with the Affordable Care Act Medicaid expansion (2014-19). J Public Health (Oxf). 2023 03 14; 45(1):99-101.
    View in: PubMed
    Score: 0.023
  15. Impact of placenta accreta spectrum (PAS) pathology on neonatal respiratory outcomes in cesarean hysterectomies. J Matern Fetal Neonatal Med. 2022 Dec; 35(26):10692-10697.
    View in: PubMed
    Score: 0.023
  16. Importance of the gynecologic oncologist in management of cesarean hysterectomy for Placenta Accreta Spectrum (PAS). Gynecol Oncol. 2022 09; 166(3):460-464.
    View in: PubMed
    Score: 0.022
  17. Correlation of clinical outcomes with the application of the 2020 consensus panel on histological classification for Placenta Accreta Spectrum (PAS). J Matern Fetal Neonatal Med. 2022 Dec; 35(25):10044-10048.
    View in: PubMed
    Score: 0.022
  18. Effect of anesthesia selection on neonatal outcomes in cesarean hysterectomies for placenta accreta spectrum (PAS). J Perinat Med. 2022 Nov 25; 50(9):1210-1214.
    View in: PubMed
    Score: 0.022
  19. Short interval pregnancy is associated with pathology severity in placenta accreta spectrum (PAS). J Matern Fetal Neonatal Med. 2022 Dec; 35(25):8863-8868.
    View in: PubMed
    Score: 0.021
  20. Neuraxial to general anesthesia conversion has equitable intraoperative and improved post-operative outcomes compared to general anesthesia in cesarean hysterectomy for placenta accreta spectrum (PAS). J Matern Fetal Neonatal Med. 2022 Dec; 35(25):8640-8644.
    View in: PubMed
    Score: 0.021
  21. Whole blood transfusion reduces overall component transfusion in cases of placenta accreta spectrum: a pilot program. J Matern Fetal Neonatal Med. 2022 Dec; 35(25):6455-6460.
    View in: PubMed
    Score: 0.020
  22. Antenatal ultrasound compared to MRI evaluation of fetal myelomeningocele: a prenatal and postnatal evaluation. J Perinat Med. 2019 Sep 25; 47(7):771-774.
    View in: PubMed
    Score: 0.018
  23. Fetal thyroid disorders: Pathophysiology, diagnosis and therapeutic approaches. J Gynecol Obstet Hum Reprod. 2019 Apr; 48(4):231-233.
    View in: PubMed
    Score: 0.017
  24. Vulvovaginitis: Find the cause to treat it. Cleve Clin J Med. 2017 Mar; 84(3):215-224.
    View in: PubMed
    Score: 0.015
  25. Sequential Amniotic Fluid Thyroid Hormone Changes Correlate with Goiter Shrinkage following in utero Thyroxine Therapy. Fetal Diagn Ther. 2016; 39(3):222-7.
    View in: PubMed
    Score: 0.014
  26. Temozolomide competes for P-glycoprotein and contributes to chemoresistance in glioblastoma cells. Cancer Lett. 2015 Oct 10; 367(1):69-75.
    View in: PubMed
    Score: 0.014
  27. Temozolomide resistance in glioblastoma occurs by miRNA-9-targeted PTCH1, independent of sonic hedgehog level. Oncotarget. 2015 Jan 20; 6(2):1190-201.
    View in: PubMed
    Score: 0.013
  28. Temozolomide induces the production of epidermal growth factor to regulate MDR1 expression in glioblastoma cells. Mol Cancer Ther. 2014 Oct; 13(10):2399-411.
    View in: PubMed
    Score: 0.013
  29. Feline bone marrow-derived mesenchymal stromal cells (MSCs) show similar phenotype and functions with regards to neuronal differentiation as human MSCs. Differentiation. 2012 Sep; 84(2):214-22.
    View in: PubMed
    Score: 0.011
  30. Prediction of survival in fetuses with left-sided congenital diaphragmatic hernia: Which method is better using MRI observed to expected total fetal lung volumes? Eur J Obstet Gynecol Reprod Biol. 2025 Apr; 307:241-246.
    View in: PubMed
    Score: 0.007
  31. Neurodevelopmental Outcomes after Fetoscopic Myelomeningocele Repair. J Pediatr. 2025 Apr; 279:114472.
    View in: PubMed
    Score: 0.007
  32. Adverse outcomes in monochorionic twins with amniotic fluid abnormalities without TTTS: A Case-Control study. Eur J Obstet Gynecol Reprod Biol. 2025 Mar; 306:132-138.
    View in: PubMed
    Score: 0.007
  33. Risk of Genetic Abnormality in Fetuses With Unilateral Versus Bilateral Pleural Effusions. Prenat Diagn. 2024 10; 44(11):1296-1303.
    View in: PubMed
    Score: 0.006
  34. Suture Characteristics after Exposure to Amniotic Fluid from an in vitro Model of Fetal Surgery. Fetal Diagn Ther. 2024; 51(5):463-473.
    View in: PubMed
    Score: 0.006
  35. Placenta accreta spectrum care infrastructure: an evidence-based review of needed resources supporting placenta accreta spectrum care. Am J Obstet Gynecol MFM. 2024 01; 6(1):101229.
    View in: PubMed
    Score: 0.006
  36. Impact of Race/Ethnicity and Insurance Status on Obstetric Outcomes: Secondary Analysis of the NuMoM2b Study. Am J Perinatol. 2024 05; 41(S 01):e2907-e2918.
    View in: PubMed
    Score: 0.006
  37. Impact of Transfer of Maternal Care for Fetal Anomalies on Maternal Depression and Anxiety Screening: A Prospective Cohort at a Tertiary Care Center. Fetal Diagn Ther. 2023; 50(4):282-288.
    View in: PubMed
    Score: 0.006
  38. Laser therapy versus expectant management for selective fetal growth restriction in monochorionic twins: A systematic review. Prenat Diagn. 2023 05; 43(5):687-698.
    View in: PubMed
    Score: 0.006
  39. Effects of delayed cord clamping on neonatal hyperbilirubinemia in pre-gestational diabetes at term. J Matern Fetal Neonatal Med. 2022 Dec; 35(25):7267-7275.
    View in: PubMed
    Score: 0.005
  40. Surgical site infection after cesarean delivery: incidence and risk factors at a US academic institution. J Matern Fetal Neonatal Med. 2018 Jul; 31(14):1873-1880.
    View in: PubMed
    Score: 0.004
  41. The bone marrow niche in support of breast cancer dormancy. Cancer Lett. 2016 09 28; 380(1):263-71.
    View in: PubMed
    Score: 0.003
  42. Exogenous CXCL12 activates protein kinase C to phosphorylate connexin 43 for gap junctional intercellular communication among confluent breast cancer cells. Cancer Lett. 2013 Apr 30; 331(1):84-91.
    View in: PubMed
    Score: 0.003
  43. Moving from the laboratory bench to patients' bedside: considerations for effective therapy with stem cells. Clin Transl Sci. 2011 Oct; 4(5):380-6.
    View in: PubMed
    Score: 0.003
  44. Developmental regulation of TAC1 in peptidergic-induced human mesenchymal stem cells: implication for spinal cord injury in zebrafish. Stem Cells Dev. 2012 Jan 20; 21(2):308-20.
    View in: PubMed
    Score: 0.003
  45. Loss of RE-1 silencing factor in mesenchymal stem cell-derived dopamine progenitors induces functional maturity. Mol Cell Neurosci. 2008 Oct; 39(2):285-90.
    View in: PubMed
    Score: 0.002
  46. Immunological properties of mesenchymal stem cells and clinical implications. Arch Immunol Ther Exp (Warsz). 2008 Jan-Feb; 56(1):1-8.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.